pd 173074 has been researched along with Cancer of the Thyroid in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medullary thyroid cancer is frequently an aggressive form of carcinoma for which there are currently no effective forms of systemic therapy." | 1.33 | Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth. ( Asa, SL; Dackiw, A; Ezzat, S; Huang, P, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| St Bernard, R | 1 |
| Zheng, L | 1 |
| Liu, W | 1 |
| Winer, D | 1 |
| Asa, SL | 2 |
| Ezzat, S | 2 |
| Huang, P | 1 |
| Dackiw, A | 1 |
2 other studies available for pd 173074 and Cancer of the Thyroid
| Article | Year |
|---|---|
Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
Topics: Adenoviridae; Animals; Blotting, Western; Carcinoma; Cell Differentiation; Cell Line; Cell Line, Tum | 2005 |
Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth.
Topics: Animals; Apoptosis; Benzamides; Carcinoma, Medullary; Cell Line, Tumor; Cell Proliferation; Drug Syn | 2005 |